Skip to content

Ketone Ester Supplementation on Neuro-cardiovascular Responses to Stress in Humans

Ketone Ester Supplementation on Neuro-cardiovascular Responses to Stress in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04881526
Enrollment
19
Registered
2021-05-11
Start date
2021-06-01
Completion date
2022-12-01
Last updated
2023-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketosis

Brief summary

Ketone ester supplementation has become increasingly popular as an athletic supplement. However, the metabolic effects of these supplements on exercise performance are controversial. One potential reason for lack of an ergogenic benefit could be the effects of ketone bodies on other bodily systems, such as the sympathetic nervous system. During exercise and stress the body increases the activity of the sympathetic nervous system. This causes blood vessels to constrict (get smaller) and can increase blood pressure. Studies have shown that ketone bodies can suppress the sympathetic nervous system in mice. Additionally, ketone ester supplementation can reduce blood pressure in healthy adults. In humans, direct measures of sympathetic activity are usually made from sympathetic outflow to muscle, also called muscle sympathetic nerve activity (MSNA). Using a ketone ester supplement, the investigators plan to measure blood pressure and sympathetic outflow to muscle at rest and during handgrip exercise and a mathematical task stress test to investigate the effect of ketones on neuro-cardiovascular stress responses.

Interventions

DIETARY_SUPPLEMENTD-beta-hydroxybutyrate

Drink containing D-beta-hydroxybutyrate administered at a dose of 395 mg/kg.

DIETARY_SUPPLEMENTPlacebo

Isocaloric flavored water with medium-chain triglyceride oil.

Sponsors

University of Guelph
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Double-blind

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 to 40 years of age * Healthy, free of known cardiovascular, metabolic, or musculoskeletal disease

Exclusion criteria

* History of smoking (within 3 months), diagnosed cardiovascular or metabolic disease, recent musculoskeletal injury preventing handgrip exercise, prescription of chronic medications other than oral contraceptives. * Current or recent (within 6 months) use of ketone ester supplementation or participation in a ketogenic diet. * Inability to abstain from drugs, caffeine, alcohol, or strenuous physical activity prior to the study visit.

Design outcomes

Primary

MeasureTime frameDescription
Muscle sympathetic nerve activityBaseline - Immediately before active and control interventionsMicroneurography of fibular nerve
Blood pressureBaseline - Immediately before active and control interventionsFinger plethysmography

Secondary

MeasureTime frameDescription
Forearm blood flowBaseline - Immediately before active and control interventionsBrachial artery Doppler ultrasound

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026